Search - tctmd.com

Displaying 661 - 680 of 790

Sort: Relevancy | Date

News Daily News

Catheter-Delivered Gene Therapy Yields Positive Signal in Advanced Heart Failure

June 23, 2015

News Daily News

Lotus Valve Tops CoreValve on Some Measures in Single-Center, Nonrandomized Study

L.A. McKeown

June 17, 2015

News Industry News

Edwards Receives FDA Approval For SAPIEN 3 Transcatheter Heart Valve

June 17, 2015

News Industry News

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

June 16, 2015

News Industry News

St. Jude Medical Receives FDA Approval to Resume U.S. Evaluation of the Portico System

June 03, 2015

News Daily News

Belgian Registry Reports Similar 3-Year Survival for Sapien, CoreValve in Transfemoral TAVR

Yael L. Maxwell

June 03, 2015

News Daily News

EuroPCR 2015 Takes on TAVR, PCI Optimization, and More

Caitlin E. Cox

May 29, 2015

News Conference News EuroPCR 2015

New, Old CoreValve Iterations Showing Reductions in Pacemaker Need, Paravalvular Leak

Yael L. Maxwell

May 22, 2015

News Conference News EuroPCR 2015

Sapien 3 Experience in Europe, Canada Shows Low Mortality, Paravalvular Leak at 30 Days

Yael L. Maxwell

May 21, 2015

News Industry News

Post-Market Study Evaluating The Boston Scientific Lotus™ Valve System Demonstrates Extremely Low PVL Rates

May 20, 2015

News Conference News EuroPCR 2015

DEFLECT III: 30-Day Results Show Successful, Safe TAVR With Novel Neuroprotection Device

Yael L. Maxwell

May 20, 2015

News Conference News EuroPCR 2015

NOTION: 2-Year Data Show Positive Outlook for TAVR in Lower-Risk Patients

Yael L. Maxwell

May 19, 2015

News Daily News

Post-TAVR Aspirin Monotherapy No Less Effective, Possibly Safer Than DAPT

May 14, 2015

News Daily News

Melody 瓣膜的长期结局良好，特别是当其与支架先行置入同时实施时

Todd Neale

May 14, 2015

News Daily News

Melody Valve Yields Good Long-term Results, Especially With Pre-Stenting

Todd Neale

May 14, 2015

News Industry News

Global Trial Finds Medtronic Micra® Transcatheter Pacemaker Meets Initial Safety Measures in Wide Range of Patients

May 14, 2015

News Daily News

Post-TAVR Thrombus May Be More Common Than Thought, Often Subclinical

L.A. McKeown

May 06, 2015

News Daily News

Silent A-fib After Acute MI Portends Poor Outcome

Yael L. Maxwell

May 01, 2015

News Daily News

Study Provides Insight Into Cerebral Embolization During TAVR

April 29, 2015

News Daily News

Length of Time Between Staged PCI, TAVR Minimally Affects Short-term Outcomes

Yael L. Maxwell

April 29, 2015

Advertisement

Catheter-Delivered Gene Therapy Yields Positive Signal in Advanced Heart Failure

Lotus Valve Tops CoreValve on Some Measures in Single-Center, Nonrandomized Study

Edwards Receives FDA Approval For SAPIEN 3 Transcatheter Heart Valve

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

St. Jude Medical Receives FDA Approval to Resume U.S. Evaluation of the Portico System

Belgian Registry Reports Similar 3-Year Survival for Sapien, CoreValve in Transfemoral TAVR

EuroPCR 2015 Takes on TAVR, PCI Optimization, and More

New, Old CoreValve Iterations Showing Reductions in Pacemaker Need, Paravalvular Leak

Sapien 3 Experience in Europe, Canada Shows Low Mortality, Paravalvular Leak at 30 Days

Post-Market Study Evaluating The Boston Scientific Lotus™ Valve System Demonstrates Extremely Low PVL Rates

DEFLECT III: 30-Day Results Show Successful, Safe TAVR With Novel Neuroprotection Device

NOTION: 2-Year Data Show Positive Outlook for TAVR in Lower-Risk Patients

Post-TAVR Aspirin Monotherapy No Less Effective, Possibly Safer Than DAPT

Melody 瓣膜的长期结局良好，特别是当其与支架先行置入同时实施时

Melody Valve Yields Good Long-term Results, Especially With Pre-Stenting

Global Trial Finds Medtronic Micra® Transcatheter Pacemaker Meets Initial Safety Measures in Wide Range of Patients

Post-TAVR Thrombus May Be More Common Than Thought, Often Subclinical

Silent A-fib After Acute MI Portends Poor Outcome

Study Provides Insight Into Cerebral Embolization During TAVR

Length of Time Between Staged PCI, TAVR Minimally Affects Short-term Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content